tiprankstipranks
Harvard Bioscience (HBIO)
NASDAQ:HBIO
US Market
HBIO
Harvard Bioscience
RESEARCH TOOLSreports
Want to see HBIO full AI Analyst Report?

Harvard Bioscience (HBIO) Income Statement

277 Followers

Harvard Bioscience Income Statement

Last quarter (Q4 2025), Harvard Bioscience's total revenue was $23.73M, a decrease of -3.34% from the same quarter last year. In Q4, Harvard Bioscience's net income was $-2.85M. See Harvard Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 86.55M$ 94.14M$ 112.25M$ 113.33M$ 118.90M
Gross Profit
$ 45.88M$ 54.77M$ 66.07M$ 60.82M$ 67.65M
Operating Expenses
$ 46.51M$ 60.98M$ 64.18M$ 67.75M$ 65.59M
Depreciation and Amortization
$ 5.95M$ 6.98M$ 7.00M$ 7.58M$ 7.62M
EBITDA
$ 5.32M$ -1.47M$ 8.03M$ 944.00K$ 9.02M
Operating Income
$ -629.00K$ -6.21M$ 1.89M$ -6.93M$ 2.07M
Other Income/Expenses
$ -56.76M$ -5.45M$ -4.45M$ -2.25M$ -2.21M
Pretax Income
$ -57.39M$ -11.66M$ -2.56M$ -9.18M$ -140.00K
Net Income
$ -56.70M$ -12.40M$ -3.42M$ -9.52M$ -288.00K
Per Share Metrics
Basic EPS
$ -12.80$ -2.80$ -0.81$ -2.30$ -0.07
Diluted EPS
$ -12.80$ -2.80$ -0.81$ -2.30$ -0.07
Weighted Average Shares Outstanding
 4.44M 4.35M 4.24M 4.14M 4.03M
Weighted Average Shares Outstanding (Diluted)
 4.44M 4.35M 4.24M 4.14M 4.03M
Currency in USD

Harvard Bioscience Earnings and Revenue History